Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genes.


Journal

Pathology international
ISSN: 1440-1827
Titre abrégé: Pathol Int
Pays: Australia
ID NLM: 9431380

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 31 08 2018
accepted: 10 01 2019
pubmed: 28 2 2019
medline: 27 6 2019
entrez: 28 2 2019
Statut: ppublish

Résumé

Solid pseudopapillary neoplasms of the pancreas are rare neoplasms that have been shown to harbor recurrent somatic pathogenic variants in the beta-catenin gene, CTNNB1. Here, we used targeted next generation sequencing to analyze these tumors for other associated mutations. Six cases of solid pseudopapillary neoplasms were studied. DNA extracted from formalin-fixed paraffin embedded tissue blocks was analyzed using the Ion Torrent platform, with the 50-gene Ampliseq Cancer Hotspot Panel v2 (CHPv2), with further variant validation performed by Sanger sequencing. Four tumors (67%) were confirmed to harbor mutations within CTNNB1, two with c.109T > G p.(Ser37Ala) and two with c.94G > A p.(Asp32Asn). One case showed a frameshift deletion in the Adenomatous Polyposis Coli gene, APC c.3964delG p.(Glu1322Lysfs*93) with a variant allele frequency of 42.6%. Sanger sequencing on non-tumoral tissue confirmed the variant was somatic. The patient with the APC mutation developed metastasis and died. In addition to the four cases harboring CTNNB1 variants, we found a case characterized by poor outcome, showing a rare frameshift deletion in the APC gene. Since the APC product interacts with beta-catenin, APC variants may, in addition to CTNNB1, contribute to the pathogenesis of solid pseudopapillary neoplasms via the Wnt signaling pathway.

Identifiants

pubmed: 30811747
doi: 10.1111/pin.12778
doi:

Substances chimiques

CTNNB1 protein, human 0
beta Catenin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-201

Informations de copyright

© 2019 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Auteurs

Jayson Wang (J)

Department of Cellular Pathology, St George's Hospital, London, UK.

Gareth Gerrard (G)

Department of Medicine, Centre for Haematology, Imperial College London, London, UK.
Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London, UK.

Ben Poskitt (B)

Sarah Cannon Molecular Diagnostics, HCA Healthcare UK, London, UK.

Kay Dawson (K)

Department of Histopathology, Imperial College London, Hammersmith Hospital, London, UK.

Pritesh Trivedi (P)

Department of Histopathology, Imperial College London, Hammersmith Hospital, London, UK.

Letizia Foroni (L)

Department of Medicine, Centre for Haematology, Imperial College London, London, UK.

Mona El-Bahrawy (M)

Department of Histopathology, Imperial College London, Hammersmith Hospital, London, UK.
Faculty of Medicine, Department of Pathology, University of Alexandria, Alexandria, Egypt.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH